Initial and innate responses to viral infections - Pattern setting in immunity or disease

Current Opinion in Microbiology

Volumn 2, Issue 4, 1999, Pages 374-381

  Biron, Christine A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 12;

CELL PROLIFERATION; CYTOTOXICITY; IMMUNE RESPONSE; IMMUNITY; INTERFERON PRODUCTION; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0033178448     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(99)80066-6     Document Type: Review

References (76)

1. Medzhitov R, Janeway CA Jr: Innate immunity: Impact on the adaptive immune response. Curr Opin Immunol 1997, 9:4-9.
2. Medzhitov R, Janeway CA Jr: Innate immune recognition and control of adaptive immune responses. Seminars Immunol 1998, 10:351-353. A brief overview of host germ-line receptor recognition of pattern structures found only on microorganisms, and the consequences of this recognition for activation of adaptive immune responses.
3. Biron CA: Role of early cytokines, including alpha and beta interferons (IFNα/β), in innate and adaptive immune responses to viral infections. Seminars Immunol 1998, 10:383-390. A brief review of known interferon-α/β anti-viral and immunoregulatory effects.
4. Ahmed R, Biron CA: Immunity to viruses. In Fundamental Immunology, Edn 4. Edited by Paul WE. Philadelphia: Lippincott-Raven; 1998:1295-1334. A thorough chapter on viral infections and the immune responses to them. Details on different types of viruses and host/pathogen interactions are presented.
5. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP: Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 1999, 17:189-220. A comprehensive review of natural killer cell responses and functions during viral infections.
6. Gutierrez-Ramos JC, Bluethmann H: Molecules and mechanisms operating in septic shock: Lessons from knockout mice. Immunol Today 1997, 18:329-334.
7. Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, Biron CA: Mechanism of interleukin 12-mediated toxicities during experimental viral infections: Role of tumor necrosis factor and glucocorticoids. J Exp Med 1995, 181:901-914.
8. Nguyen KB, Biron CA: Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: Roles for natural killer and T cell IFN-γ production. J Immunol 1999, 162:5238-5246. This paper presents studies of endogenous cytokine responses to lipopolysaccharide (LPS) in uninfected and virus-infected mice. Synergistic effects between LPS and endogenous lymphocytic choriomeningitis virus (LCMV) infections for expression of interferon-γ and induction of disease are characterized.
9. Vilcek J, Sen GC: Interferons and other cytokines. In Fundamental Virology, Edn 3. Edited by Fields BN, Knipe DM, Howley PM. New York: Lippincott-Raven; 1996:341-365.
10. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR: Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci USA 1994, 91:6288-6292.
11. Lenardo MJ, Fan CM, Maniatis T, Baltimore D: The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 1989, 57:287-294.
12. Kirchhoff S, Wilhelm D, Angel P, Hauser H: NFkappaB activation is required for interferon regulatory factor-1-mediated interferon beta induction. Eur J Biochem 1999, 261:546-554.
13. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T: Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1998, 1:507-518. The authors characterize a pathway for activation of Interferon (IFN) during viral infections. Specifically, an identified virus-activated factor (VAV) is shown to contain IRF-3 and IRF-7 and to be recruited to the IFN-β promoter.
14. Sato M, Tanaka N, Hata N, Oda E, Taniguchi T: Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett 1998, 425:112-116. The role of IRF-3 in induced activation of Interferon (IFN)-β after viral infection of cells is examined.
15. Schafer SL, Lin R, Moore PA, Hiscott J, Pitha PM: Regulation of type 1 interferon gene expression by interferon regulatory factor-3. J Biol Chem 1998, 273:2714-2720. This paper biochemically characterizes the role for IRF-3 in activation of Interferon (IFN)-α4 and IFN-β genes. Results presented indicate that IRF-3 does not work alone, but can cooperate with other factors to stimulate expression of the IFN genes in particular cell types
16. Juang Y, Lowther W, Kellum M, Au WC, Lin R, Hiscott J, Pitha PM: Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci USA 1998, 95:9837-9842. Further characterization of the role for IRF-3 in interferon (IFN) expression. Data are presented indicating that anti-viral activity of IRF-3 results primarily from IFN induction in particular cells.
17. Marie I, Durbin JE, Levy DE: Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 1998, 17:6660-6669. These elegant studies dissect the steps in induction of particular interferon (IFN)-α/β genes after virus challenge of cells. An immediate early response of IFN-α4 followed by an IFN-α/β-receptor- and IRF-7-dependent induction of other IFN-α genes is characterized.
18. Lebon P: Inhibition of herpes simplex virus type-1 induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs. J Gen Virol 1985, 66:2781-2786.
19. Feldman SB, Ferraro M, Zheng H-M, Patel N, Gould-Fogerite, Fitzgerald-Bocarsly P: Viral induction of low frequency interferon-α producing cells. Virology 1994, 201:1-7.
20. Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Röllinghoff M, Gresser I, Bogdan C: Type 1 interferon (IFN-α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998, 8:77-87.
21. Tokunaga T, Yano O, Kuramoto E, Kimura Y, Yamamoto T, Kataoka T, Yamamoto A: Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol 1992, 36:55-66.
22. Ballas ZK, Rasmussen WL, Krieg AM: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996, 157:1840-1845.
23. Grundy (Chalmer) JE, Trapman J, Allan JE, Shellam GR, Melief CJM: Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infect Immun 1982, 37:143-150.
24. Welsh RM: Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med 1978, 148:163-181.
25. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998, 395:284-288.
26. Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995, 13:437-457.
27. Scherle PA, Jones EA, Favata MF, Daulerio AJ, Covington MB, Nurnberg SA, Magolda RL, Trzaskos JM: Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipoplysaccharide-stimulated monocytes. J Immunol 1998, 161:5681-5686.
28. Swantek JL, Christerson L, Cobb MH: Lipopolysaccharide-induced tumor necrosis factor-alpha promoter activity is inhibitor of nuclear factor-kappaB kinase-dependent J Biol Chem 1999, 274:11667-11671.
29. Ulevitch RJ, Tobias PS: Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999, 11:19-22. A review of the biochemical events required for recognition of and induction of innate responses by lipopolysaccharide.
30. Wysocka M, Kubin M, Vieira LQ, Ozmen L, Garotta G, Scott P, Trinchieri G: Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol 1995, 25:672-676.
31. Biron CA, Gazzinelli RT: Effects of IL-12 on immune responses to microbial infections: A key mediator in regulating disease outcome. Curr Opin Immunol 1995, 7:485-496.
32. Orange JS, Wang B, Terhorst C, Biron CA: Requirement for natural killer (NK) cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interelukin 12 administration. J Exp Med 1995, 182:1045-1056.
33. Orange JS, Biron CA: An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and anitviral defense. J Immunol 1996, 156:1138-1142.
34. Orange JS, Biron CA: Characterization of early IL-12, IFN-α/β, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 1996, 156:4746-4756.
35. Kanagat S, Thomas J, Gangappa S, Babu JS, Rouse BT: Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J Immunol 1996, 156:1110-1116.
36. Kanangat S, Babu JS, Knipe DM, Rouse BT: HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: Selective upregulation of IL-6 gene expression. Virology 1996, 219:295-300.
37. Thomas J, Kanangat S, Rouse BT: Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: Implications in herpetic stromal keratitis. J Interferon Cytokine Res 1998, 18:681-690.
38. Heise MT, Virgin HW: The T cell independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol 1995, 69:904-909.
39. Ruzek MC, Miller AH, Opal SM, Pearce BD, Biron CA: Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J Exp Med 1997, 185:1185-1192.
40. Ruzek MC, Pearce BD, Miller AH, Biron CA: Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. J Immunol 1999, 162:3527-3533. This study characterizes the importance of an induced glucocorticoid response for protection against cytokine-mediated disease. The results demonstrate that magnitudes of the endogenous initial/innate tumor necrosis factor-α (TNF-α), interleukin (IL)-6, IL-12 and interferon-γ (IFN-γ) cytokine responses are negatively regulated by glucocorticoids, and that these hormones act to protect the host from TNF-mediated lethality.
41. Pulliam L, Moore D, West DC: Human cytomegalovirus induces IL-6 and TNF alpha from macrophages and microglial cells: Possible role in neurotoxicity. J Neuroviral 1995, 1:219-227.
42. Monteiro JM, Harvey C, Trinchieri G: Role of interleukin-12 in primary influenza virus infection. J Virol 1998, 72:4825-4831. This paper reports on the induction and function of interleukin (IL)-12 for natural killer (NK) cell interferon-γ (IFN-γ) responses, and apparent IL-12-independent T cell IFN-γ responses during influenza virus infections.
43. Darnell JE Jr: STATS and gene regulation. Science 1997, 277:1630-1635.
44. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993, 261:1445-1448.
45. MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 1997, 15:323-350.
46. Biron CA, Orange JS: IL12 in acute viral infectious disease. Res Immunol 1995, 146:590-600.
47. Cousens LP, Orange JS, Su HC, Biron CA: IFN-α/β inhibition of IL-12 and IFN-γ production in vitro and endogenously during viral infection. Proc Natl Acad Sci USA 1997, 94:634-639.
48. Cousens LP, Peterson R, Hsu S, Dorner A, Altman JD, Ahmed R, Biron CA: Two roads diverged: Interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection. J Exp Med 1999, 189:1315-1327. The authors define the existence of two possible pathways for promoting T cell interferon (IFN)-γ responses during viral infections. Results identify a dominant pathway under the control of IFN-α/β, and reveal a second interleukin (IL)-12-dependent pathway in the absence of IFN-α/β-mediated effects.
49. Ma X, Riemann H, Gri G, Trinchieri G: Positive and negative regulation of interleukin-12 gene expression. Eur Cytokine Netw 1998, 9:54-64.
50. Chehimi J, Starr SE, Frank SE, D'Andrea D, Ma X, MacGregor RR, Sennelier J, Trinchieri G: Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994, 179:1361-1366.
51. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE: Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996, 273:228-231.
52. Biron CA: Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 1997, 9:24-34.
53. Duncan GS, Mittrucker H-W, Kagi D, Matsuyama T, Mak TW: The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J Exp Med 1996, 184:2043-2048.
54. Zhang X, Sun S, Hwang I, Tough DF, Sprent J: Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998, 8:591-599. This paper reports the sensitivity of memory but not naive T cells for IL-15 driven proliferation.
55. Williams NS, Klem J, Puzanov IJ, Sivakumar PV, Schatzle JD, Bennett M, Kumar V: Natural killer cell differentiation: Insights from knockout and transgenic mouse models and in vitro systems. Immunol Rev 1998, 165:47-61. A thoughtful review of known requirements for natural killer (NK) cell development as elucidated through studies in genetically mutated mice and in tissue culture.
56. Waldmann TA, Tagaya Y: The multifaceted regulation of interleukin 15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999, 17:19-49. A comprehensive review of interleukin (IL)-15 and its role in natural killer (NK) cell development and function.
57. Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, Yokochi-Fukuda T, Waldmann TA, Taniguchi T, Taki S: Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 1998, 391:700-703. This paper characterizes mechanisms for the IRF-1 contribution to natural killer cell development as mediated through radiation-resistant bone-marrow microenvironment cells and secondary to effects on interleukin (IL)-15 expression.
58. Ohteki T, Yoshida H, Matsuyama T, Duncan GS, Mak TW, Ohashi PS: The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+T) cells, natural killer cells, and intestinal intraepithelial T cells. J Exp Med 1998, 187:967-972. Additional studies on IRF-1 requirements for maturation of several cell populations including classic natural killer cells are reported.
59. Biron CA, Byron KS, Sullivan JL: Severe herpesvirus infections in an adolescent without natural killer cells. New Eng J Med 1989, 320:1731-1735.
60. Salazar-Mather TP, Orange JS, Biron CA: Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J Exp Med 1998, 187:1-14. A thorough study characterizing the trafficking of natural killer (NK) cells to mediate anti-viral defense in infected livers. Results identify requirements for local accumulation of NK cells and NK cell-interferon-γ production, and the role of a chemokine, MIP-1α, for directing this localization in optimal resistance to infection.
61. Tay CH, Welsh RM: Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 1997, 71:267-275.
62. McEwen BS, Biron CA, Brunson KW, Bulloch K, Chambers WH, Dhabhar FS, Goldfarb RH, Kitson RP, Miller AH, Spencer RL, Weiss JM: The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions. Brain Res Rev 1997, 23:79-133.
63. Orange JS, Salazar-Mather TP, Opal SM, Biron CA: Mechanisms for virus-induced liver disease: Tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J Virol 1997, 71:9248-9258.
64. Orange JS, Wolf SF, Biron CA: Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 1994, 152:1253-1264.
65. Kasaian MT, Biron CA: The activation of IL-2 transcription in L3T4+ and Lyt-2+ lymphocytes during virus infection in vivo. J Immunol 1989, 142:1287-1292.
66. Cousens LP, Orange JS, Biron CA: Endogenous IL-2 contributes to T cell expansion and IFN-γ production during lymphocytic choriomeningitis virus infection. J Immunol 1995, 155:5690-5699.
67. + T cell interactions in IFN-γ and IL-4 responses to viral infections: Requirements for IL-2. J Immunol 1998, 160:5007-5017.
68. Schijns VECJ, Haagmans BL, Wierda CMH, Kruithof B, Heijnen IAFM, Alber G, Hornizek MC: Mice lacking IL-12 develop polarized Th1 cells during viral infection. J Immunol 1998, 160:3958-3964. This study demonstrates interleukin (IL)-12-independent T cell interferon-γ responses during mouse hepatitis virus infections of mice rendered IL-12-deficient as a result of genetic mutation.
69. + T cell Th1-dependent antibody, responses during lymphocytic choriomeningitis virus (LCMV) or vesicular stomatitis virus (VSV) infections of mice rendered IL-12-deficient as a result of genetic mutation.
70. + T cells. J Exp Med 1993, 178:1655-1663.
71. Manetti R, Annuziato F, Tomasevic L, Gianno V, Parronchi P, Romagnani S, Maggi E: Polyinosinic acid: Polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interieron-α and interleukin-12. Eur J Immunol 1995, 25:2656-2660.
72. Saraneva T, Matikainen S, Kurimoto M, Julkunen I: Influenza A virus induced IFN-α/β and IL-18 synergistically enhance IFN-γ gene expression in human T cells. J Immunol 1998, 160:6032-6038. Potent synergistic effects of Interferon (IFN)-α/β and interleukin (IL)-18 for enhancing human T cell IFN-γ expression in culture are reported. The studies indicate that the effects on IFN-γ expression are independent of IL-12.
73. Wenner CA, Guler ML, Macatonia SE, O'Garra A, Murphy KM: Roles of IFN-γ and IFN-α in IL-12-induced T helper cell-1 development. J Immunol 1996, 156:1442-1447.
74. Tough DF, Borrow P, Sprent J: Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996, 272:1947-1950.
75. Sun S, Zhang X, Tough DF, Sprent J: Type 1 interferon-mediated stimulation of T cells by CpG DNA. J Exp Med 1998, 188:2335-2342. Studies investigating the role for Interferon (IFN)-α/β in stimulation of T cell responses by CpG DNA are presented. Experimental results show that the activation marker, CD69, is induced under these conditions through a pathway dependent upon the IFN-α/βR.
76. Marrack P, Kappler J, Mitchell T: Type 1 interferons keep activated T cells alive. J Exp Med 1999, 189:521-530. This paper reports effects of Interferon (IFN)-α/β on prolonging T cell survival following stimulation.